Trabectedin for advanced soft tissue sarcomas: optimizing use

por Reid, Alison, Martin-Liberal, Juan, Benson, Charlotte
Publicado 2014

Blockade of novel immune checkpoints and new therapeutic combinations to boost antitumor immunity

por Archilla-Ortega, Adrià, Domuro, Carla, Martin-Liberal, Juan, Muñoz, Purificación
Publicado 2022

Pazopanib is an active treatment in desmoid tumour/aggressive fibromatosis

por Martin-Liberal, Juan, Benson, Charlotte, McCarty, Heather, Thway, Khin, Messiou, Christina, Judson, Ian
Publicado 2013

Pazopanib as first line treatment for solitary fibrous tumours: the Royal Marsden Hospital experience

por Maruzzo, Marco, Martin-Liberal, Juan, Messiou, Christina, Miah, Aisha, Thway, Khin, Alvarado, Rolyn, Judson, Ian, Benson, Charlotte
Publicado 2015

Caveolin-1 in sarcomas: friend or foe?

por Sáinz-Jaspeado, Miguel, Martin-Liberal, Juan, Lagares-Tena, Laura, Mateo-Lozano, Silvia, del Muro, Xavier Garcia, Tirado, Oscar M
Publicado 2011

Targeted Therapies in Sarcomas: Challenging the Challenge

por Martín Liberal, Juan, Lagares-Tena, Laura, Sáinz-Jaspeado, Miguel, Mateo-Lozano, Silvia, García del Muro, Xavier, Tirado, Oscar M.
Publicado 2012

First-in-human, dose-escalation, phase 1 study of anti-angiopoietin-2 LY3127804 as monotherapy and in combination with ramucirumab in patients with advanced solid tumours

por Martin-Liberal, Juan, Hollebecque, Antoine, Aftimos, Philippe, Jungels, Christiane, Martin-Romano, Patricia, Rodon, Jordi, Kremer, Jill Dolores, Zhang, Wei, Bendell, Johanna
Publicado 2020

First line palliative chemotherapy in elderly patients with advanced soft tissue sarcoma

por Yousaf, Nadia, Harris, Samuel, Martin-Liberal, Juan, Stanway, Susannah, Linch, Mark, Ifijen, Maria, Al Muderis, Omar, Khabra, Komel, Fisher, Cyril, Noujaim, Jonathan, Judson, Ian, Benson, Charlotte
Publicado 2015

Myasthenia Gravis Induced by Immune Checkpoint Inhibitors: An Emerging Neurotoxicity in Neuro-Oncology Practice: Case Series

por Marco, Carla, Simó, Marta, Alemany, Montse, Casasnovas, Carlos, Domínguez, Raúl, Vilariño, Noelia, Calvo, Mariona, Martín-Liberal, Juan, Brenes, Jesús, Sabater-Riera, Joan, Bruna, Jordi, Velasco, Roser
Publicado 2022

A Phase 1/2 study of the PD-L1 inhibitor, BGB-A333, alone and in combination with the PD-1 inhibitor, tislelizumab, in patients with advanced solid tumours

por Desai, Jayesh, Fong, Peter, Moreno, Victor, Frentzas, Sophia, Meniawy, Tarek, Markman, Ben, Voskoboynik, Mark, Rahman, Tahmina, Budha, Nageshwar, Wu, John, Marlow, Jin, Yang, Silu, Calvo, Emiliano, Martin-Liberal, Juan
Publicado 2023

SWI/SNF Complex Alterations in Tumors with Rhabdoid Features: Novel Therapeutic Approaches and Opportunities for Adoptive Cell Therapy

por Soto-Castillo, Juan José, Llavata-Marti, Lucía, Fort-Culillas, Roser, Andreu-Cobo, Pablo, Moreno, Rafael, Codony, Carles, García del Muro, Xavier, Alemany, Ramon, Piulats, Josep M., Martin-Liberal, Juan
Publicado 2023

Ramucirumab Plus Pembrolizumab in Patients with Previously Treated Advanced or Metastatic Biliary Tract Cancer: Nonrandomized, Open‐Label, Phase I Trial (JVDF)

por Arkenau, Hendrik‐Tobias, Martin‐Liberal, Juan, Calvo, Emiliano, Penel, Nicolas, Krebs, Matthew G., Herbst, Roy S., Walgren, Richard A., Widau, Ryan C., Mi, Gu, Jin, Jin, Ferry, David, Chau, Ian
Publicado 2018

EphA2-Induced Angiogenesis in Ewing Sarcoma Cells Works through bFGF Production and Is Dependent on Caveolin-1

por Sáinz-Jaspeado, Miguel, Huertas-Martinez, Juan, Lagares-Tena, Laura, Martin Liberal, Juan, Mateo-Lozano, Silvia, de Alava, Enrique, de Torres, Carmen, Mora, Jaume, del Muro, Xavier Garcia, Tirado, Oscar M.
Publicado 2013

Regorafenib treatment for advanced, refractory gastrointestinal stromal tumor: a report of the UK managed access program

por Kollàr, Attila, Maruzzo, Marco, Messiou, Christina, Cartwright, Elisabeth, Miah, Aisha, Martin-Liberal, Juan, Thway, Khin, McGrath, Ellen, Dunlop, Alison, Khabra, Komel, Seddon, Beatrice, Dileo, Palma, Linch, Mark, Judson, Ian, Benson, Charlotte
Publicado 2014

The Comparative Effectiveness of Innovative Treatments for Cancer (CEIT-Cancer) project: Rationale and design of the database and the collection of evidence available at approval o...

por Ladanie, Aviv, Speich, Benjamin, Naudet, Florian, Agarwal, Arnav, Pereira, Tiago V., Sclafani, Francesco, Martin-Liberal, Juan, Schmid, Thomas, Ewald, Hannah, Ioannidis, John P. A., Bucher, Heiner C., Kasenda, Benjamin, Hemkens, Lars G.
Publicado 2018

Clinical Activity and Tolerability of a 14-Day Infusional Ifosfamide Schedule in Soft-Tissue Sarcoma

por Martin-Liberal, Juan, Alam, Salma, Constantinidou, Anastasia, Fisher, Cyril, Khabra, Komel, Messiou, Christina, Olmos, David, Mitchell, Scott, Al-Muderis, Omar, Miah, Aisha, Linch, Mark, Jones, Robin L., Scurr, Michelle, Judson, Ian, Benson, Charlotte
Publicado 2013

Clinical Trial Evidence Supporting US Food and Drug Administration Approval of Novel Cancer Therapies Between 2000 and 2016

por Ladanie, Aviv, Schmitt, Andreas M., Speich, Benjamin, Naudet, Florian, Agarwal, Arnav, Pereira, Tiago V., Sclafani, Francesco, Herbrand, Amanda K., Briel, Matthias, Martin-Liberal, Juan, Schmid, Thomas, Ewald, Hannah, Ioannidis, John P. A., Bucher, Heiner C., Kasenda, Benjamin, Hemkens, Lars G.
Publicado 2020

First-in-human phase I/II, open-label study of the anti-OX40 agonist INCAGN01949 in patients with advanced solid tumors

por Davis, Elizabeth J, Martin-Liberal, Juan, Kristeleit, Rebecca, Cho, Daniel C, Blagden, Sarah P, Berthold, Dominik, Cardin, Dana B, Vieito, Maria, Miller, Rowan E, Hari Dass, Prashanth, Orcurto, Angela, Spencer, Kristen, Janik, John E, Clark, Jason, Condamine, Thomas, Pulini, Jennifer, Chen, Xuejun, Mehnert, Janice M
Publicado 2022

Exploring the Immunogenicity of Noncanonical HLA-I Tumor Ligands Identified through Proteogenomics

por Lozano-Rabella, Maria, Garcia-Garijo, Andrea, Palomero, Jara, Yuste-Estevanez, Anna, Erhard, Florian, Farriol-Duran, Roc, Martín-Liberal, Juan, Ochoa-de-Olza, Maria, Matos, Ignacio, Gartner, Jared J., Ghosh, Michael, Canals, Francesc, Vidal, August, Piulats, Josep Maria, Matías-Guiu, Xavier, Brana, Irene, Muñoz-Couselo, Eva, Garralda, Elena, Schlosser, Andreas, Gros, Alena
Publicado 2023

A Phase I Study Investigating AZD8186, a Potent and Selective Inhibitor of PI3Kβ/δ, in Patients with Advanced Solid Tumors

por Choudhury, Atish D., Higano, Celestia S., de Bono, Johann S., Cook, Natalie, Rathkopf, Dana E., Wisinski, Kari B., Martin-Liberal, Juan, Linch, Mark, Heath, Elisabeth I., Baird, Richard D., García-Carbacho, Javier, Quintela-Fandino, Miguel, Barry, Simon T., de Bruin, Elza C., Colebrook, Steve, Hawkins, George, Klinowska, Teresa, Maroj, Brijesh, Moorthy, Ganesh, Mortimer, Peter G., Moschetta, Michele, Nikolaou, Myria, Sainsbury, Liz, Shapiro, Geoffrey I., Siu, Lillian L., Hansen, Aaron R.
Publicado 2022